Back

Lysosome-related biomarkers LUM and SERPINA3 for dilated cardiomyopathy: a diagnostic signature linked to immune-cell infiltration

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Improving understanding of disease in dilated cardiomyopathy Dilated Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Zhuqing Li

Tianjin First Center Hospital, Tianjin (China)

6 More presentations in this session

Presentation thumbnail
Systematic assessment of DSP missense variants in a cohort of patients with left ventricular cardiomyopathy
Mr M. Bergier (Buenos Aires, AR)
Abstract
Presentation thumbnail
Genotype influences the risk and age of onset of atrial fibrillation in patients with dilated cardiomyopathy
Doctor D. Cannie (London, GB)
Abstract
Presentation thumbnail
Plasma lipid signatures in recent-onset dilated cardiomyopathy: a targeted lipidomics study
Doctor Y. Xie (CN)
Abstract
Presentation thumbnail
Genetic variant spectrum in dilated and non-dilated left ventricular cardiomyopathy
Doctor S. Khoury (Tel Aviv, IL)
Abstract
Presentation thumbnail
Dilated cardiomyopathy: does the right ventricle have an impact on prognostic outcomes?
Doctor J. Faria (Braga, PT)
Abstract

Access the full session

Session thumbnail
Improving understanding of disease in dilated cardiomyopathy

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Comprehensive proteomics profiling identifies patients with late gadolinium enhancement on cardiac magnetic resonance imaging in the hypertrophic cardiomyopathy population
27 August 2021
thumbnail
Congress Presentation
The source of liberation of dipeptidyl peptidase 3 (DPP3), a newly emerged cardiac biomarker, in pathological situations
20 May 2023
thumbnail
Congress Presentation
Relationship of inflammatory and metabolic processes in patients with dilated cardiomyopathy and chronic heart failure.
29 June 2021
thumbnail
Congress Presentation
S100A9 blockade ameliorates cardiac dysfunction and reduces myocardial immune infiltration in experimental autoimmune myocarditis
1 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources